Full video transcriptClick to expand
Auto-generated transcript of @thewellnessway_knoxville's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Hey Doc, that's the number one thing to increase libido in women.
- 0:05To increase libido.
- 0:06Well first of all I would say it's kind of a medical mindset right to always have to stimulate
- 0:10or inhibit.
- 0:11Why not just normalize it?
- 0:13So to have a normal libido you've got to have your adrenals in checked meaning they're
- 0:18not stressed out.
- 0:19So in women about 25% of your testosterone is produced by your adrenals and so if you're
- 0:25super stressed out it's going to tank your adrenals, it's going to tank your hormones
- 0:29and you won't function properly.
- 0:32So deal with the stress super super important.
- 0:34Now obviously there's other things you can support your adrenals with ashwagandha or ammonia
- 0:39or licorice or some liquid herbs but again that just depends on the patients.
- 0:43Bottom line deal with your stress.
Low libido and supplements: what the evidence actually says
Quick answer
The video addresses low libido in women through an adrenal-androgen lens, claiming that chronic stress suppresses adrenal testosterone production and recommending stress management plus select adaptogens. While HPA axis dysregulation does affect androgen levels and sexual desire, the clinical workup for hypoactive sexual desire disorder should include ovarian function, medication history, mental health screening, and hormone panels, not adrenal status alone. Licorice root, named as a supplement option, carries a documented risk of androgen suppression and hypertension that makes its inclusion in a libido-support context clinically questionable without significant caveats.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Low libido and supplements: what the evidence actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Low libido and supplements: what the evidence actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Low libido and supplements: what the evidence actually says" from TheWellnessWay_KnoxvilleW. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video addresses low libido in women through an adrenal-androgen lens, claiming that chronic stress suppresses adrenal testosterone production and recommending stress management plus select adaptogens.
The reason this review is not generic is the source wording and the canonical claim label "trt low libido there are ways to supoort your body with suppleme." In this clip, the useful excerpt is: "Hey Doc, that's the number one thing to increase libido in women." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video addresses low libido in women through an adrenal-androgen lens, claiming that chronic stress suppresses adrenal testosterone production and recommending stress management plus select adaptogens.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video addresses low libido in women through an adrenal-androgen lens, claiming that chronic stress suppresses adrenal testosterone production and recommending stress management plus select adaptogens. While HPA axis dysregulation does affect androgen levels and sexual desire, the clinical workup for hypoactive sexual desire disorder should include ovarian function, medication history, mental health screening, and hormone panels, not adrenal status alone. Licorice root, named as a supplement option, carries a documented risk of androgen suppression and hypertension that makes its inclusion in a libido-support context clinically questionable without significant caveats.
- Adrenal glands do contribute to androgen production in women, primarily through DHEA and DHEA-S precursors, but the contribution varies substantially by age and menopausal status and is not a fixed 25% across all women.
- Chronic stress suppresses the HPG axis through cortisol and CRH elevation, and Brotto et al. (2010, Journal of Sexual Medicine) confirmed direct links between psychological stress and reduced sexual desire in women.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Adrenal glands do contribute to androgen production in women, primarily through DHEA and DHEA-S precursors, but the contribution varies substantially by age and menopausal status and is not a fixed 25% across all women.
- Chronic stress suppresses the HPG axis through cortisol and CRH elevation, and Brotto et al. (2010, Journal of Sexual Medicine) confirmed direct links between psychological stress and reduced sexual desire in women.
- Adrenal fatigue is not a recognized clinical diagnosis per the Endocrine Society. HPA axis dysregulation from chronic stress is real and measurable, but it is not the same as adrenal gland insufficiency.
- Licorice root can reduce testosterone levels in women. Armanini et al. (2003, Experimental and Clinical Endocrinology and Diabetes) found significant testosterone reduction with regular licorice consumption, which is the opposite of what you want when addressing low libido.
- The ISSWSH 2019 consensus position supports transdermal testosterone therapy for postmenopausal women with diagnosed HSDD under clinical supervision, meaning there are evidence-based medical options beyond supplement and stress management protocols.
- Ashwagandha has meaningful cortisol-lowering evidence and some data supporting improved sexual function in stressed adults, making it the most defensible herb in the video's supplement list.
- Low libido has multiple documented causes including SSRI and hormonal contraceptive use, thyroid dysfunction, relationship factors, and mental health conditions. A single adrenal-stress explanation risks missing the actual driver in many patients.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @thewellnessway_knoxville actually say?
The creator, appearing to be a clinician, argued that low libido in women is fundamentally a stress and adrenal problem, not a hormone deficiency requiring intervention. Their core claim: "about 25% of your testosterone is produced by your adrenals," and chronic stress will "tank your adrenals" and "tank your hormones." They also mentioned ashwagandha, ammonia (likely a slip for "ashwagandha" said twice, or possibly "ammonium"), licorice, and liquid herbs as adrenal supports, while consistently returning to stress management as the primary fix.
To their credit, they explicitly pushed back on what they called "a medical mindset" of always stimulating or inhibiting, framing the goal as normalization. That framing is actually reasonable, even if the downstream claims get complicated.
Does the science back this up?
Partially, yes. The adrenal-testosterone connection in women is real and documented, but the "25%" figure is where things get slippery. The evidence on stress, cortisol, and libido is genuinely solid, though the mechanism is more complex than the video suggests.
Women produce androgens, including testosterone, from three main sources: the ovaries, the adrenal glands, and peripheral conversion of precursors like DHEA. The adrenals do contribute meaningfully. Burger et al. (2002, Journal of Clinical Endocrinology and Metabolism) established that adrenal androgens, particularly DHEA and DHEA-S, account for a significant share of circulating androgens in women, especially after menopause when ovarian contribution drops. The exact percentage varies by a woman's age, cycle phase, and menopausal status, so a flat "25%" is an oversimplification.
The stress-libido link is better supported. Brotto et al. (2010, Journal of Sexual Medicine) documented how psychological stress directly impairs sexual desire in women through both hormonal and cognitive pathways. Elevated cortisol suppresses gonadotropin-releasing hormone, which does compress the entire reproductive hormone cascade. So "deal with the stress" is not wrong advice.
What did they get wrong (or right)?
They got the general direction right but oversimplified the mechanism in ways that could mislead viewers.
Saying stress will "tank your adrenals" implies adrenal fatigue as a clinical entity, which remains contested. The Endocrine Society does not recognize adrenal fatigue as a medical diagnosis. What chronic stress does do, via HPA axis dysregulation, is measurable and real, but it is not the same as adrenal gland failure or insufficiency. Conflating the two is a common wellness-space move that sounds scientific without quite being accurate.
The herb list deserves scrutiny too. Ashwagandha has the strongest evidence here. Wankhede et al. (2015, Journal of the International Society of Sports Nutrition) found ashwagandha supplementation reduced cortisol and improved sexual function in stressed adults. Licorice root, however, contains glycyrrhizin, which can actually suppress testosterone and raise blood pressure with regular use. Tying it to libido support without that caveat is a meaningful omission. The "ammonia" mention is unclear from the transcript and may be a verbal error.
Their framing of normalization over stimulation or inhibition is genuinely good clinical thinking and does not get enough credit in hormone conversations.
What should you actually know?
Low libido in women is not a single-cause problem, and no single supplement is a fix. That part of the message holds up.
The clinical picture for hypoactive sexual desire disorder (HSDD) in women involves multiple intersecting factors: hormonal status, relationship context, mental health, medications (SSRIs and oral contraceptives are well-documented libido suppressors), sleep quality, and yes, stress. Clayton et al. (2018, International Journal of Women's Health) reviewed the complexity of HSDD diagnosis and noted that a purely adrenal or cortisol-focused explanation accounts for only a slice of the real picture.
Testosterone therapy for women with low libido has actual regulatory and evidence history. The International Society for the Study of Women's Sexual Health (ISSWSH) published a 2019 consensus position supporting transdermal testosterone for postmenopausal women with HSDD under proper clinical supervision. That is a real option, and framing every low-libido case as primarily a stress management issue could delay someone from getting an evidence-based evaluation.
If you are dealing with low libido, the right first step is a proper workup, including hormone panels, medication review, and a conversation with a provider who takes the full picture seriously, not just a supplement stack.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
TheWellnessWay_KnoxvilleW · TikTok creator
364.8K views on this video
Low libido? There are ways to supoort your body with supplements but the most important thing is dealing with your stressors!! If you struggle doing this on your own, send us a message. We’d love to help assist you on your joirney! 💚 #women #libido #lowlibido #womenshealth #adrenals #thewellnessway #hormones #stress #stressed #couples #coupleoftiktok #womenoftikiok
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about adrenal glands do contribute to?
Adrenal glands do contribute to androgen production in women, primarily through DHEA and DHEA-S precursors, but the contribution varies substantially by age and menopausal status and is not a fixed 25% across all women.
What does the video say about chronic stress suppresses the hpg axis through cortisol?
Chronic stress suppresses the HPG axis through cortisol and CRH elevation, and Brotto et al. (2010, Journal of Sexual Medicine) confirmed direct links between psychological stress and reduced sexual desire in women.
What does the video say about adrenal fatigue?
Adrenal fatigue is not a recognized clinical diagnosis per the Endocrine Society. HPA axis dysregulation from chronic stress is real and measurable, but it is not the same as adrenal gland insufficiency.
What does the video say about licorice root can reduce testosterone levels in women. armanini et?
Licorice root can reduce testosterone levels in women. Armanini et al. (2003, Experimental and Clinical Endocrinology and Diabetes) found significant testosterone reduction with regular licorice consumption, which is the opposite of what you want when addressing low libido.
What does the video say about the isswsh 2019 consensus position supports transdermal testosterone therapy for?
The ISSWSH 2019 consensus position supports transdermal testosterone therapy for postmenopausal women with diagnosed HSDD under clinical supervision, meaning there are evidence-based medical options beyond supplement and stress management protocols.
What does the video say about ashwagandha has meaningful cortisol-lowering evidence?
Ashwagandha has meaningful cortisol-lowering evidence and some data supporting improved sexual function in stressed adults, making it the most defensible herb in the video's supplement list.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by TheWellnessWay_KnoxvilleW, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.